CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 190 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $12 | 0.0% | 776 | +1.0% | 0.01% | 0.0% |
Q1 2024 | $12 | 0.0% | 768 | +9.1% | 0.01% | 0.0% |
Q4 2023 | $12 | +71.4% | 704 | +20.1% | 0.01% | +60.0% |
Q3 2023 | $7 | -22.2% | 586 | -12.8% | 0.01% | -28.6% |
Q2 2023 | $9 | -76.3% | 672 | -70.8% | 0.01% | -78.8% |
Q1 2023 | $38 | -53.7% | 2,303 | -47.6% | 0.03% | 0.0% |
Q4 2022 | $82 | -99.7% | 4,392 | +95.2% | 0.03% | +26.9% |
Q3 2022 | $29,000 | -9.4% | 2,250 | -50.3% | 0.03% | +4.0% |
Q2 2022 | $32,000 | -20.0% | 4,530 | -7.1% | 0.02% | -7.4% |
Q1 2022 | $40,000 | +900.0% | 4,878 | +768.0% | 0.03% | +350.0% |
Q4 2021 | $4,000 | – | 562 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 7,097,300 | $27,750,000 | 4.54% |
GREAT POINT PARTNERS LLC | 3,817,288 | $14,926,000 | 2.55% |
TANAKA CAPITAL MANAGEMENT INC | 256,593 | $1,003,000 | 2.29% |
Consonance Capital Management LP | 4,473,607 | $17,492,000 | 1.58% |
Avoro Capital Advisors LLC | 3,892,343 | $15,219,000 | 0.99% |
KNOTT DAVID M | 380,110 | $1,486,000 | 0.59% |
EAM Investors, LLC | 790,872 | $3,092,000 | 0.55% |
Ghost Tree Capital, LLC | 550,000 | $2,151,000 | 0.50% |
EAM Global Investors LLC | 251,647 | $984,000 | 0.50% |
MANGROVE PARTNERS IM, LLC | 924,648 | $3,615,000 | 0.49% |